Annual ROE
1364.32%
-1113.35%-44.94%
31 December 2022
Summary:
Nymox Pharmaceutical annual return on equity is currently 1364.32%, with the most recent change of -1113.35% (-44.94%) on 31 December 2022. During the last 3 years, it has risen by +1784.06% (+425.04%).NYMX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-1589.50%
+732.12%+31.53%
31 March 2023
Summary:
Nymox Pharmaceutical quarterly return on equity is currently -1589.50%, with the most recent change of +732.12% (+31.53%) on 31 March 2023.NYMX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | +425.0% | -231.8% |
| 5 y5 years | +470.3% | -724.8% |
NYMX ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -74.8% | -165.2% |
Nymox Pharmaceutical ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -1589.50%(-31.5%) |
| Dec 2022 | 1364.32%(-44.9%) | -2321.62%(-20.0%) |
| Sept 2022 | - | -2902.43%(+41.3%) |
| June 2022 | - | -2053.99%(+48.6%) |
| Mar 2022 | - | -1382.25%(+74.6%) |
| Dec 2021 | 2477.67%(-690.3%) | -791.78%(+65.3%) |
| Sept 2021 | - | -479.09%(-26.9%) |
| June 2021 | - | -655.51%(-28.0%) |
| Mar 2021 | - | -909.82%(+52.1%) |
| Dec 2020 | -419.74%(+66.6%) | -598.02%(+28.5%) |
| Sept 2020 | - | -465.43%(+48.2%) |
| June 2020 | - | -314.06%(+37.2%) |
| Mar 2020 | - | -228.90%(+17.4%) |
| Dec 2019 | -251.90%(-31.6%) | -194.97%(+1.2%) |
| Sept 2019 | - | -192.71%(-8.4%) |
| June 2019 | - | -210.43%(-8.3%) |
| Mar 2019 | - | -229.51%(-47.2%) |
| Dec 2018 | -368.42%(-134.3%) | -434.61%(-59.7%) |
| Sept 2018 | - | -1078.17%(-90.9%) |
| June 2018 | - | -11.89 K%(-772.7%) |
| Mar 2018 | - | 1767.76%(+3.0%) |
| Dec 2017 | 1073.46%(-80.2%) | 1716.17%(-29.7%) |
| Sept 2017 | - | 2439.51%(+109.7%) |
| June 2017 | - | 1163.45%(+34.5%) |
| Mar 2017 | - | 864.78%(+8.2%) |
| Dec 2016 | 5417.36%(+612.4%) | 799.61%(+20.4%) |
| Sept 2016 | - | 663.97%(-19.1%) |
| June 2016 | - | 820.69%(-9.2%) |
| Mar 2016 | - | 903.57%(+38.6%) |
| Dec 2015 | 760.48%(+658.3%) | 651.92%(+50.8%) |
| Sept 2015 | - | 432.25%(+220.2%) |
| June 2015 | - | 135.01%(+1372.3%) |
| Mar 2015 | - | 9.17%(-88.8%) |
| Dec 2014 | 100.29%(+32.0%) | 82.10%(-8.1%) |
| Sept 2014 | - | 89.34%(-0.7%) |
| June 2014 | - | 89.96%(-6.4%) |
| Mar 2014 | - | 96.12%(+31.8%) |
| Dec 2013 | 76.00%(-21.8%) | 72.91%(-19.4%) |
| Sept 2013 | - | 90.49%(+2.9%) |
| June 2013 | - | 87.95%(-0.9%) |
| Mar 2013 | - | 88.78%(-8.5%) |
| Dec 2012 | 97.23%(-43.6%) | 97.04%(+9.4%) |
| Sept 2012 | - | 88.68%(-12.6%) |
| June 2012 | - | 101.50%(-12.4%) |
| Mar 2012 | - | 115.89%(-37.8%) |
| Dec 2011 | 172.44%(-24.7%) | 186.39%(-16.7%) |
| Sept 2011 | - | 223.70%(-23.0%) |
| June 2011 | - | 290.44%(-25.6%) |
| Mar 2011 | - | 390.25%(+9.4%) |
| Dec 2010 | 228.97% | 356.56%(-12.2%) |
| Sept 2010 | - | 406.18%(-14.3%) |
| June 2010 | - | 473.88%(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | 495.49%(+9.2%) |
| Dec 2009 | 353.26%(-132.7%) | 453.88%(+10.3%) |
| Sept 2009 | - | 411.68%(-103.3%) |
| June 2009 | - | -12.38 K%(+1947.1%) |
| Mar 2009 | - | -604.70%(+84.0%) |
| Dec 2008 | -1080.16%(+225.9%) | -328.68%(+41.0%) |
| Sept 2008 | - | -233.18%(+10.5%) |
| June 2008 | - | -211.02%(-6.1%) |
| Mar 2008 | - | -224.74%(-9.5%) |
| Dec 2007 | -331.47%(-51.3%) | -248.41%(-12.3%) |
| Sept 2007 | - | -283.30%(-11.5%) |
| June 2007 | - | -320.21%(-23.8%) |
| Mar 2007 | - | -420.08%(-23.8%) |
| Dec 2006 | -680.31%(+54.2%) | -551.51%(+1.7%) |
| Sept 2006 | - | -542.40%(+9.2%) |
| June 2006 | - | -496.77%(+4.1%) |
| Mar 2006 | - | -477.20%(+4.6%) |
| Dec 2005 | -441.30%(+58.5%) | -456.38%(+19.9%) |
| Sept 2005 | - | -380.61%(+15.5%) |
| June 2005 | - | -329.53%(+6.8%) |
| Mar 2005 | - | -308.69%(+11.7%) |
| Dec 2004 | -278.37%(+14.0%) | -276.32%(-0.3%) |
| Sept 2004 | - | -277.02%(+5.2%) |
| June 2004 | - | -263.44%(+19.7%) |
| Mar 2004 | - | -220.15%(+5.2%) |
| Dec 2003 | -244.24%(+68.9%) | -209.34%(+24.0%) |
| Sept 2003 | - | -168.79%(+3.5%) |
| June 2003 | - | -163.11%(+15.9%) |
| Mar 2003 | - | -140.70%(+1.0%) |
| Dec 2002 | -144.64%(+40.1%) | -139.29%(+4.2%) |
| Sept 2002 | - | -133.63%(+6.0%) |
| June 2002 | - | -126.06%(+10.1%) |
| Mar 2002 | - | -114.51%(+12.1%) |
| Dec 2001 | -103.27%(-41.4%) | -102.17%(+4.0%) |
| Sept 2001 | - | -98.23%(-3.4%) |
| June 2001 | - | -101.69%(-1.8%) |
| Mar 2001 | - | -103.56%(-16.2%) |
| Dec 2000 | -176.18%(+32.7%) | -123.57%(-4.3%) |
| Sept 2000 | - | -129.17%(-1.7%) |
| June 2000 | - | -131.35%(+18.2%) |
| Mar 2000 | - | -111.10%(-13.0%) |
| Dec 1999 | -132.72%(-14.2%) | -127.71%(+4.9%) |
| Sept 1999 | - | -121.73%(+8.0%) |
| June 1999 | - | -112.67%(-7.1%) |
| Mar 1999 | - | -121.23%(-7.5%) |
| Dec 1998 | -154.68%(+10.5%) | -131.03%(+12.2%) |
| Sept 1998 | - | -116.81%(+7.2%) |
| June 1998 | - | -108.98%(-4.9%) |
| Mar 1998 | - | -114.64%(+10.1%) |
| Dec 1997 | -140.00% | -104.11%(+40.6%) |
| Sept 1997 | - | -74.05%(+82.6%) |
| June 1997 | - | -40.55% |
FAQ
- What is Nymox Pharmaceutical annual return on equity?
- What is the all time high annual ROE for Nymox Pharmaceutical?
- What is Nymox Pharmaceutical quarterly return on equity?
- What is the all time high quarterly ROE for Nymox Pharmaceutical?
What is Nymox Pharmaceutical annual return on equity?
The current annual ROE of NYMX is 1364.32%
What is the all time high annual ROE for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual return on equity is 5417.36%
What is Nymox Pharmaceutical quarterly return on equity?
The current quarterly ROE of NYMX is -1589.50%
What is the all time high quarterly ROE for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly return on equity is 2439.51%